{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:04:56Z","timestamp":1774710296011,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1991,2,1]],"date-time":"1991-02-01T00:00:00Z","timestamp":665366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1991,2]]},"DOI":"10.1007\/bf01880446","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T20:35:23Z","timestamp":1120509323000},"page":"72-75","source":"Crossref","is-referenced-by-count":43,"title":["Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"1","author":[{"given":"R.","family":"Muff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Dambacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01880446_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0026-0495(84)90187-2","volume":"33","author":"HE Gruber","year":"1984","unstructured":"Gruber HE, Ivey JL, Baylink DJ et al. Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 1984; 33:295\u2013303.","journal-title":"Metabolism"},{"key":"BF01880446_CR2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0026-0495(85)90120-9","volume":"34","author":"JF Aloia","year":"1985","unstructured":"Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH. Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 1985; 34:124\u20139.","journal-title":"Metabolism"},{"key":"BF01880446_CR3","first-page":"455","volume":"38","author":"C Gennari","year":"1985","unstructured":"Gennari C, Chierichetti SM, Bigazzi S et al. Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis. Cur Ther Res 1985; 38:455\u201364.","journal-title":"Cur Ther Res"},{"key":"BF01880446_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02556587","volume":"38","author":"GF Mazzuoli","year":"1986","unstructured":"Mazzuoli GF, Passeri M, Gennari C et al. Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study. Calcif Tissue Int 1986; 38:3\u20138.","journal-title":"Calcif Tissue Int"},{"key":"BF01880446_CR5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(87)92619-5","volume":"ii","author":"JY Reginster","year":"1987","unstructured":"Reginster JY, Albert A, Lecart MP et al. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 1987; ii:1481\u20133.","journal-title":"Lancet"},{"key":"BF01880446_CR6","first-page":"90O","volume":"i","author":"I MacIntyre","year":"1988","unstructured":"MacIntyre I, Whitehead MI, Banks LM, Stevenson JC, Wimalawansa SJ, Healy MJR. Calcitonin for prevention of postmenopausal bone loss. Lancet 1988; i:90O-2.","journal-title":"Lancet"},{"key":"BF01880446_CR7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1172\/JCI113725","volume":"82","author":"R Civitelli","year":"1988","unstructured":"Civitelli R, Gonnelli S, Zacchei F et al. Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment. J Clin Invest 1988; 82:1268\u201374.","journal-title":"J Clin Invest"},{"key":"BF01880446_CR8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.299.6697.477","volume":"299","author":"K Overgaard","year":"1989","unstructured":"Overgaard K, Riis BJ, Christiansen C, Hansen MA. Effect of salcatonin given intranasally on early postmenopausal bone loss. Br Med J 1989; 299:477\u20139.","journal-title":"Br Med J"},{"key":"BF01880446_CR9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02556039","volume":"45","author":"H Resch","year":"1989","unstructured":"Resch H, Pietschmann P, Willvonseder R. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures. Calcif Tissue Int 1989; 45:209\u201313.","journal-title":"Calcif Tissue Int"},{"key":"BF01880446_CR10","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(74)90072-5","volume":"ii","author":"S Rojanasathit","year":"1974","unstructured":"Rojanasathit S, Rosenberg E, Haddad JG Jr. Paget's bone disease: Response to human calcitonin in patients resistant to salmon calcitonin. Lancet 1974; ii:1412\u201315.","journal-title":"Lancet"},{"key":"BF01880446_CR11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/art.1780231012","volume":"23","author":"FR Singer","year":"1980","unstructured":"Singer FR, Fredericks RS, Minkin C. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance. Arthritis Rheum 1980; 23:1148\u201353.","journal-title":"Arthritis Rheum"},{"key":"BF01880446_CR12","first-page":"394","volume":"2","author":"FR Singer","year":"1984","unstructured":"Singer FR, Mills BG. Paget's disease of bone: Etiologic and therapeutic aspects. J Bone Min Res 1984; 2:394\u2013421.","journal-title":"J Bone Min Res"},{"key":"BF01880446_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03348394","volume":"7","author":"V Lo Cascio","year":"1984","unstructured":"Lo Cascio V, Adami S, Galvanini G et al. Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin. J Endocrinol Invest 1984; 7:85\u201388.","journal-title":"J Endocrinol Invest"},{"key":"BF01880446_CR14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archinte.1987.00370070119017","volume":"147","author":"RD Altman","year":"1987","unstructured":"Altman RD, Collins-Yudiskas B. Synthetic human calcitonin in refractory Paget's disease of bone. Arch Intern Med 1987; 147:1305\u20138.","journal-title":"Arch Intern Med"},{"key":"BF01880446_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0002-9343(90)90297-Q","volume":"89","author":"R Muff","year":"1990","unstructured":"Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin. Am J Med 1990; 89:181\u20134.","journal-title":"Am J Med"},{"key":"BF01880446_CR16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1210\/jcem-67-3-541","volume":"67","author":"F Levy","year":"1988","unstructured":"Levy F, Muff R, Dotti-Sigrist S, Dambacher MA, Fischer JA. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease. J Clin Endocrinol Metab 1988; 67:541\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01880446_CR17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/acta.0.0800465","volume":"80","author":"FM Dietrich","year":"1975","unstructured":"Dietrich FM, Hunziker WH, Fischer JA. Synthetic human calcitonin: Analysis of antibodies obtained from various animal species and determination of immunoreactive hormone in human sera. Acta Endocrinol (Copenh) 1975; 80:465\u201386.","journal-title":"Acta Endocrinol"},{"key":"BF01880446_CR18","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.75.8.3984","volume":"75","author":"J Moran","year":"1978","unstructured":"Moran J, Hunziker W, Fischer JA. Calcitonin and calcium ionophores: Cyclic AMP responses in cells of a human lymphoid line. Proc Natl Acad Sci USA 1978; 75:3984\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01880446_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2265.1982.tb01598.x","volume":"17","author":"W Born","year":"1982","unstructured":"Born W, Dambacher MA, Meyrier A, Ardaillou R, Fischer JA. Parathyroid suppressibility in hyperparathyroidism due to chronic renal failure: Studies with autotransplanted parathyroid tissue. Clin Endocrinol 1982; 17:333\u201343.","journal-title":"Clin Endocrinol"},{"key":"BF01880446_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jbmr.5650050412","volume":"5","author":"A Grauer","year":"1990","unstructured":"Grauer A, Raue F, Schneider H-G, Frank-Raue K, Ziegler R. In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin. J Bone Min Res 1990; 5:387\u201391.","journal-title":"J Bone Min Res"},{"key":"BF01880446_CR21","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1172\/JCI107140","volume":"51","author":"JG Haddad Jr","year":"1972","unstructured":"Haddad JG Jr, Caldwell JG. Calcitonin resistance: Clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins. J Clin Invest 1972; 51: 3133\u201341.","journal-title":"J Clin Invest"},{"key":"BF01880446_CR22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0002-9343(74)90815-8","volume":"56","author":"J DeRose","year":"1974","unstructured":"DeRose J, Singer FR, Avramides A et al. Response of Paget's disease to porcine and salmon calcitonins: Effects of long-term treatment. Am J Med 1974; 56:858\u201366.","journal-title":"Am J Med"},{"key":"BF01880446_CR23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1530\/acta.0.0920468","volume":"92","author":"FM Dietrich","year":"1979","unstructured":"Dietrich FM, Fischer JA, Bijvoet OLM. Formation of antibodies to synthetic human calcitonin during treatment of Paget's disease. Acta Endocrinol (Copenh) 1979; 92:468\u201376.","journal-title":"Acta Endocrinol"},{"key":"BF01880446_CR24","first-page":"285","volume":"34","author":"AH Tashjian Jr","year":"1978","unstructured":"Tashjian AH Jr, Wright DR, Ivey JL, Pont A. Calcitonin binding sites in bone: Relationships to biological response and 'escape'. Recent Prog Horm Res 1978; 34:285\u2013334.","journal-title":"Recent Prog Horm Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01880446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01880446\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01880446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T23:07:50Z","timestamp":1557443270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01880446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,2]]}},"alternative-id":["BF01880446"],"URL":"https:\/\/doi.org\/10.1007\/bf01880446","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,2]]}}}